From April 2014 the funding of the NJR was changed from a levy on the sales of implants to a subscription-based model, with the subscription charge being based on the number of procedures submitted to the NJR.
Trusts, Local Health Boards and independent sector healthcare providers are now invoiced directly by the Healthcare Quality Improvement Partnership (HQIP) which hosts the registry's accounts. A report from the NJRSC Chairman can be found here.
Income and expenditure 2018/19
The NJR is self-financing and from 1 April 2014 has been funded by a subscription paid by Trusts, Health Boards and independent sector healthcare providers. Moving to this model, from the previous model based on a levy charged on the sale of hip, knee, ankle, elbow, and shoulder implants, has reduced the cost of the NJR to the NHS.
The rate of the subscription is recommended by the NJR Steering Committee for approval by NHS England, and is subject to a Memorandum of Understanding between NHS England, Welsh Government, Health and Social Care Board Northern Ireland, and the Independent Healthcare Advisory Services.
During 2018/19, subscriptions totalling £3,376,379 were collected from NHS and independent sector providers (2017/18: £2,904,090). Other income of £687,320 (2017/18: £586,466) included supplier contributions and income from the NJR’s price benchmarking service.
Expenditure on the management and development of the National Joint Registry was £3,676,664 (2017/18: £3,719,441). This included governance costs of £186,570 (2017/18: £157,298).
Full 2018/19 accounts
The NJR’s financial results are included in the audited accounts of HQIP who host the registry. The full audited accounts are available on HQIP’s website from November 2019, and also from the Charity Commission and Companies House.